Titre : Benzoate de sodium

Benzoate de sodium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzoate de sodium : Questions médicales les plus fréquentes", "headline": "Benzoate de sodium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzoate de sodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-08", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzoate de sodium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acide benzoïque", "url": "https://questionsmedicales.fr/mesh/D019817", "about": { "@type": "MedicalCondition", "name": "Acide benzoïque", "code": { "@type": "MedicalCode", "code": "D019817", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.127.117" } } }, "about": { "@type": "MedicalCondition", "name": "Benzoate de sodium", "alternateName": "Sodium Benzoate", "code": { "@type": "MedicalCode", "code": "D020160", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chieh-Hsin Lin", "url": "https://questionsmedicales.fr/author/Chieh-Hsin%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan." } }, { "@type": "Person", "name": "Hsien-Yuan Lane", "url": "https://questionsmedicales.fr/author/Hsien-Yuan%20Lane", "affiliation": { "@type": "Organization", "name": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan." } }, { "@type": "Person", "name": "Andrea Baker", "url": "https://questionsmedicales.fr/author/Andrea%20Baker", "affiliation": { "@type": "Organization", "name": "Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia." } }, { "@type": "Person", "name": "Anne Gordon", "url": "https://questionsmedicales.fr/author/Anne%20Gordon", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Royal Brisbane and Women's Hospital, Herston, Australia." } }, { "@type": "Person", "name": "George Bruxner", "url": "https://questionsmedicales.fr/author/George%20Bruxner", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Caboolture and Redcliffe Hospitals, Caboolture, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.", "datePublished": "2023-10-13", "url": "https://questionsmedicales.fr/article/37833775", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s40249-023-01145-5" } }, { "@type": "ScholarlyArticle", "name": "Indicators of the National Immunization Program for children under one year old: time trend in Maranhão, Brazil, 2010 to 2021.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/37531541", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1413-81232023288.07312023" } }, { "@type": "ScholarlyArticle", "name": "Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.", "datePublished": "2024-06-26", "url": "https://questionsmedicales.fr/article/38925146", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2024.2362449" } }, { "@type": "ScholarlyArticle", "name": "Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.", "datePublished": "2023-11-19", "url": "https://questionsmedicales.fr/article/37989612", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.11.029" } }, { "@type": "ScholarlyArticle", "name": "Post-epidemic health system recovery: A comparative case study analysis of routine immunization programs in the Republics of Haiti and Liberia.", "datePublished": "2023-10-17", "url": "https://questionsmedicales.fr/article/37847680", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0292793" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Benzoates", "item": "https://questionsmedicales.fr/mesh/D001565" }, { "@type": "ListItem", "position": 8, "name": "Acide benzoïque", "item": "https://questionsmedicales.fr/mesh/D019817" }, { "@type": "ListItem", "position": 9, "name": "Benzoate de sodium", "item": "https://questionsmedicales.fr/mesh/D020160" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzoate de sodium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzoate de sodium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzoate de sodium", "description": "Comment diagnostiquer une allergie au benzoate de sodium ?\nQuels tests sont utilisés pour évaluer l'exposition au benzoate ?\nQuels symptômes indiquent une intoxication au benzoate ?\nComment évaluer une réaction cutanée au benzoate ?\nLe benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzoate de sodium", "description": "Quels sont les symptômes d'une hypersensibilité au benzoate ?\nLe benzoate de sodium cause-t-il des effets secondaires ?\nComment se manifeste une réaction allergique au benzoate ?\nLe benzoate de sodium peut-il provoquer des troubles digestifs ?\nQuels symptômes neurologiques peuvent être liés au benzoate ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzoate de sodium", "description": "Comment éviter les allergies au benzoate de sodium ?\nQuelles alternatives au benzoate de sodium existent ?\nLes enfants doivent-ils éviter le benzoate ?\nComment sensibiliser sur les dangers du benzoate ?\nLe benzoate de sodium est-il sûr dans les aliments ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzoate de sodium", "description": "Quel traitement pour une réaction allergique au benzoate ?\nComment traiter une intoxication au benzoate de sodium ?\nY a-t-il des antidotes pour le benzoate de sodium ?\nComment gérer les effets secondaires du benzoate ?\nLe benzoate de sodium nécessite-t-il un suivi médical ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzoate de sodium", "description": "Quelles complications peuvent survenir avec une allergie au benzoate ?\nLe benzoate de sodium peut-il affecter le foie ?\nY a-t-il des risques de cancer liés au benzoate ?\nLe benzoate de sodium peut-il affecter le système nerveux ?\nQuelles sont les conséquences d'une surconsommation ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzoate de sodium", "description": "Qui est le plus à risque d'allergie au benzoate ?\nLes personnes asthmatiques sont-elles à risque ?\nLe risque d'allergie augmente-t-il avec l'âge ?\nLes personnes ayant des maladies chroniques sont-elles à risque ?\nLe mode de vie influence-t-il le risque d'allergie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Immunization+Programs&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie au benzoate de sodium ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests cutanés ou des tests sanguins pour détecter des anticorps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition au benzoate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire peuvent mesurer les niveaux de benzoate dans le sang ou l'urine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au benzoate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment évaluer une réaction cutanée au benzoate ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique et un historique médical détaillé sont nécessaires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être détecté dans des tests spécifiques de toxicologie alimentaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hypersensibilité au benzoate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des démangeaisons, des éruptions cutanées et des maux de tête." } }, { "@type": "Question", "name": "Le benzoate de sodium cause-t-il des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées et des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment se manifeste une réaction allergique au benzoate ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des urticaires, des gonflements et des difficultés respiratoires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il provoquer des troubles digestifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des troubles digestifs comme des douleurs abdominales et des diarrhées." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent être liés au benzoate ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête et des vertiges peuvent être observés." } }, { "@type": "Question", "name": "Comment éviter les allergies au benzoate de sodium ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments contenant du benzoate et lisez attentivement les étiquettes." } }, { "@type": "Question", "name": "Quelles alternatives au benzoate de sodium existent ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des conservateurs naturels comme l'acide citrique ou le vinaigre peuvent être utilisés." } }, { "@type": "Question", "name": "Les enfants doivent-ils éviter le benzoate ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sensibles devraient éviter le benzoate en raison de risques d'hyperactivité." } }, { "@type": "Question", "name": "Comment sensibiliser sur les dangers du benzoate ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des étiquettes claires peuvent aider à sensibiliser." } }, { "@type": "Question", "name": "Le benzoate de sodium est-il sûr dans les aliments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement considéré comme sûr en quantités réglementées, mais des précautions s'imposent." } }, { "@type": "Question", "name": "Quel traitement pour une réaction allergique au benzoate ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antihistaminiques et les corticostéroïdes peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment traiter une intoxication au benzoate de sodium ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour le benzoate de sodium ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires du benzoate ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de réduire l'exposition et de consulter un médecin pour des conseils." } }, { "@type": "Question", "name": "Le benzoate de sodium nécessite-t-il un suivi médical ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est recommandé en cas de réactions sévères ou d'allergies confirmées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une allergie au benzoate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves comme un choc anaphylactique peuvent survenir dans des cas extrêmes." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des troubles hépatiques, bien que rare." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés au benzoate ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel avec certains cancers, mais les preuves sont limitées." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le système nerveux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des effets neurologiques, comme des maux de tête." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une surconsommation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des réactions allergiques." } }, { "@type": "Question", "name": "Qui est le plus à risque d'allergie au benzoate ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Les personnes asthmatiques sont-elles à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes asthmatiques peuvent être plus sensibles aux effets du benzoate." } }, { "@type": "Question", "name": "Le risque d'allergie augmente-t-il avec l'âge ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le risque d'allergie peut augmenter chez les enfants, mais il varie selon les individus." } }, { "@type": "Question", "name": "Les personnes ayant des maladies chroniques sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladies chroniques peuvent avoir une sensibilité accrue." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'allergie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'allergies alimentaires, y compris au benzoate." } } ] } ] }

Sources (10000 au total)

Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.

Migrant and left-behind families are vulnerable in health services utilization, but little is known about their disparities in immunization of non-National Immunization Program (NIP) vaccines. This st... A cross-sectional survey was conducted in urban areas of Zhejiang and rural areas of Henan in China. A total of 1648 caregivers of children aged 1-6 years were interviewed face-to-face by a pre-design... The immunization coverage of all non-NIP vaccines and knowledge of all items of local urban families was the highest, followed by migrant, non-left-behind and left-behind families. Compared with local... There were immunization disparities in non-NIP vaccines among migrant and left-behind families compared with their local counterparts. Non-NIP vaccination promotion strategies, including education on ...

Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region.

There is limited literature on current human papillomavirus (HPV) vaccination in the Asia-Pacific region. This integrative literature review was conducted to describe HPV vaccination programs in Hong ...

Strengthening immunization programs through innovative sub-national public-private partnerships in selected provinces in the Democratic Republic of the Congo.

Low immunization coverage rates in the Democratic Republic of Congo (DRC) have been reflective of challenges with vaccine access, support and delivery in the country. Motivated by measles and vaccine-... These MoUs were 5-year partnerships designed to aid provinces in meeting four key objectives: 80 % immunization coverage, management/elimination of polio/cVDPV outbreaks, improvement of vaccine access... During the MoU period, Haut-Lomami saw an increase in full immunization coverage, from 35.7 % (MICS 2018) to 88.9 % (VCS 2021-22), the highest in country. A sharp drop in percentage of zero-dose child... Ultimately, the provincial MoUs were successful in bolstering provincial autonomy and capacity building with the biggest success being a drop in zero-dose children. While not all objectives have been ...

The equity road ahead for financing non-national immunization program vaccines in China: challenges and opportunities from a qualitative study.

In China, national immunization program (NIP) vaccines benefit from robust financial support and have achieved high coverage. Non-NIP vaccines rely on fragmented funding sources, mostly out-of-pocket ... Between July and December 2023, we conducted a series of semi-structured, in-person interviews with 55 stakeholders from the Health Bureau, Centers for Disease Control and Prevention, Medical Insuranc... Non-NIP vaccine financing sources include out-of-pocket payments, government fiscal, health insurance and other external funds. These four channels differ in vaccine types covered, costs, and target p... Relying on individual payments as the main financing channel for non-NIP vaccines is unsustainable and inadequate for ensuring universal vaccine access. A concerted and synergistic approach is essenti...

Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage.

Infant vaccination coverage rates in Peru have declined in recent years, exacerbated by the COVID-19 pandemic. Introduction of the fully-liquid diphtheria, tetanus, and acellular pertussis (DTaP)-inac... The analysis was performed over a 5-year period on a cohort of children born in Peru in 2020 (N = 494,595). Four scenarios were considered: the pentavalent plus IPV/OPV scheme (S1); replacing the pent... The overall cost from a public health payer perspective associated with the pentavalent plus IPV/OPV vaccine scheme (S1) was estimated at $56,719,350, increasing to $61,324,263 (+ 8.1%), $59,121,545 (... Implementation of the hexavalent vaccine in Peru's National Immunization Program has a positive public health cost consequence....